Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8301
FT Vest US Equity Deep Buffer ETF September
DSEP
$353M
| $906K | ﹤0.01% |
28,266
+12,031
| +74% | +$388K |
|
8302
CALL
Karyopharm Therapeutics
KPTI
$43.1M
| $906K | ﹤0.01% |
10,373
+6,960
| +204% | +$722K |
|
|
TPH
8303
CALL
DELISTED
Tri Pointe Homes
TPH
| $906K | ﹤0.01% |
43,100
+27,300
| +173% | +$615K |
|
8304
UGI
UGI
$8.42B
| $906K | ﹤0.01% |
21,250
-164,506
| -89% | -$7.52M |
|
|
CPLB
8305
NYLI MacKay Core Plus Bond ETF
CPLB
$379M
| $906K | ﹤0.01% |
+36,227
| New | +$914K |
|
|
SAFE
8306
PUT
DELISTED
Safehold Inc.
SAFE
| $906K | ﹤0.01% |
12,600
+7,100
| +129% | +$602K |
|
8307
CALL
Citi Trends
CTRN
$604M
| $905K | ﹤0.01% |
12,400
-30,200
| -71% | -$2.42M |
|
8308
Donnelley Financial Solutions
DFIN
$1.21B
| $905K | ﹤0.01% |
26,144
+12,079
| +86% | +$399K |
|
8309
Future Fuel
FF
$243M
| $905K | ﹤0.01% |
126,804
-534,794
| -81% | -$4.44M |
|
8310
McEwen Inc
MUX
$1.13B
| $904K | ﹤0.01% |
86,931
-11,350
| -12% | -$130K |
|
8311
CALL
SouthState Bank Corp
SSB
$10.6B
| $904K | ﹤0.01% |
12,100
+6,100
| +102% | +$435K |
|
|
PRVB
8312
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $904K | ﹤0.01% |
141,215
-32,499
| -19% | -$209K |
|
8313
PUT
ACI Worldwide
ACIW
$5.28B
| $903K | ﹤0.01% |
29,400
+22,000
| +297% | +$730K |
|
8314
PUT
Popular Inc
BPOP
$11.2B
| $901K | ﹤0.01% |
11,600
-23,200
| -67% | -$1.73M |
|
8315
PUT
Capital Southwest
CSWC
$1.57B
| $901K | ﹤0.01% |
35,800
-6,100
| -15% | -$159K |
|
|
VXRT
8316
PUT
DELISTED
Vaxart
VXRT
| $901K | ﹤0.01% |
113,300
-250,600
| -69% | -$2.06M |
|
8317
PUT
Atossa Therapeutics
ATOS
$26.2M
| $900K | ﹤0.01% |
18,413
-27,360
| -60% | -$1.59M |
|
8318
PUT
Ichor Holdings
ICHR
$2.45B
| $900K | ﹤0.01% |
21,900
-9,300
| -30% | -$425K |
|
|
MQT
8319
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $899K | ﹤0.01% |
+62,495
| New | +$922K |
|
8320
PUT
Dr. Reddy's Laboratories
RDY
$10.1B
| $899K | ﹤0.01% |
69,000
+52,500
| +318% | +$700K |
|
8321
PUT
MSC Industrial Direct
MSM
$6.86B
| $898K | ﹤0.01% |
11,200
-12,400
| -53% | -$1.05M |
|
8322
CALL
TriplePoint Venture Growth BDC
TPVG
$225M
| $898K | ﹤0.01% |
+56,700
| New | +$888K |
|
8323
PUT
Grocery Outlet
GO
$1.11B
| $897K | ﹤0.01% |
41,600
-35,300
| -46% | -$1.02M |
|
|
SPCK
8324
PUT
The SPAC and New Issue ETF
SPCK
$8.24M
| $897K | ﹤0.01% |
31,200
-47,900
| -61% | -$1.38M |
|
|
TRTX
8325
TPG RE Finance Trust
TRTX
$604M
| $897K | ﹤0.01% |
72,464
+59,449
| +457% | +$761K |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.